Obtained More than $40 Million in Settlements for Victims of Alleged Blood Reagents Price-Fixing Conspiracy

October 25, 2018

In re: Blood Reagents Antitrust Litigation, 09-md-02081 (E.D. Penn.)

Robins Kaplan served on the executive committee in this class action, which alleged that defendants Ortho Clinical Diagnostics, Inc., a former Johnson & Johnson subsidiary, colluded with Immucor, Inc. to raise prices on traditional blood reagents, which are used to test blood before transfusions and donations. Aggregate settlements totaled more than $40 million and the case concluded in October 2018. Notably, the Department of Justice had initially opened a criminal investigation into defendants’ practices, but subsequently closed the investigation without taking any action.

Past results are reported to provide the reader with an indication of the type of litigation we practice. They do not and should not be construed to create an expectation of result in any other case, as all cases are dependent upon their own unique fact situation and applicable law.
Disclaimer

Related Practices

Antitrust and Trade Regulation

Similar Results

$19.5 Million Settlement Secured for Indirect Buyers in Interior Molded Doors Antitrust Litigation
Antitrust and Trade Regulation Business Litigation Class Action Litigation
Secured $7.2 Million Resolving Alleged Monopolization of Oncology Services
Antitrust and Trade Regulation
Defended Supervalu in Extensive Antitrust Class Action Litigation
Antitrust and Trade Regulation Appellate Advocacy and Guidance Business Litigation Class Action Litigation
Achieved Extraordinary $6.26 Billion Settlement in Interchange Fee Litigation
Antitrust and Trade Regulation Business Litigation Class Action Litigation
Secured Settlement of $432 Million in Class Action Against Wells Fargo
Antitrust and Trade Regulation Business Litigation Class Action Litigation
Secured $76.8 Million Verdict on Behalf of Health Insurers in Direct Action Alleging Unlawful Monopolization of Prescription Drugs
Antitrust and Trade Regulation Business Litigation Direct Actions and Opt-Out Practice
Secured in Excess of $1.2 Billion in Settlements in Air Cargo Shipping Services Antitrust Litigation
Antitrust and Trade Regulation Business Litigation Class Action Litigation
Obtained Full Dismissal for Graco in Putative Nationwide Antitrust Class Action
Antitrust and Trade Regulation Appellate Advocacy and Guidance Business Litigation Class Action Litigation
Obtained Nearly $600 Million in Settlements in Class Action Against Private Equity Firms
Antitrust and Trade Regulation Business Litigation Class Action Litigation
Obtained Full Dismissal for Carlson Hotels, Inc. and Radisson Hotels International, Inc. in Antitrust Lawsuit
Business Litigation Antitrust and Trade Regulation
Secured More Than $400 Million in Settlements on Behalf of Best Buy in Direct Action Alleging Price-Fixing of Cathode Ray Tubes
Antitrust and Trade Regulation Business Litigation Direct Actions and Opt-Out Practice
Secured More Than $250 Million in Settlements on Behalf of Agribusiness Clients Alleging Price-Fixing of Vitamins
Antitrust and Trade Regulation Business Litigation Direct Actions and Opt-Out Practice
Obtained Full Dismissal for UnitedHealth Group, Inc. and PacifiCare, Inc. in Antitrust Lawsuit
Antitrust and Trade Regulation Business Litigation Health Care Litigation
Secured $35 Million in Settlements on Behalf of Clients, Resolving Allegations of Price-Fixing Cartel Among Leading Manufacturers of Methionine
Antitrust and Trade Regulation Business Litigation Direct Actions and Opt-Out Practice
Secured $6.5 Billion Settlement in Historic Big Tobacco Lawsuit
Antitrust and Trade Regulation Trademark, Advertising, and Brand Litigation
Back to Top